Clinical Trial Update: Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating temozolomide in patients with relapsed or progressive small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED